ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,451,000 | +33.7% | 20,052 | -2.5% | 0.02% | +40.0% |
| Q2 2021 | $2,581,000 | -5.1% | 20,565 | +2.6% | 0.02% | -16.7% |
| Q1 2021 | $2,719,000 | +1.4% | 20,049 | -4.3% | 0.02% | +5.9% |
| Q4 2020 | $2,682,000 | -14.2% | 20,960 | -24.5% | 0.02% | -26.1% |
| Q3 2020 | $3,126,000 | -2.4% | 27,775 | -17.4% | 0.02% | -8.0% |
| Q2 2020 | $3,202,000 | +31.8% | 33,611 | -48.3% | 0.02% | +316.7% |
| Q3 2017 | $2,429,000 | +20.2% | 65,051 | -2.1% | 0.01% | +20.0% |
| Q2 2017 | $2,020,000 | +11.9% | 66,474 | -2.5% | 0.01% | 0.0% |
| Q1 2017 | $1,805,000 | +6.5% | 68,182 | +2.7% | 0.01% | 0.0% |
| Q4 2016 | $1,695,000 | +59.9% | 66,406 | +89.5% | 0.01% | +66.7% |
| Q3 2014 | $1,060,000 | -16.9% | 35,038 | -6.7% | 0.00% | 0.0% |
| Q2 2014 | $1,276,000 | – | 37,552 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 1,480,060 | $53,563,000 | 85.86% |
| NEXTHERA CAPITAL LP | 217,817 | $7,883,000 | 4.84% |
| Novo Holdings A/S | 903,833 | $32,710,000 | 2.90% |
| SECTORAL ASSET MANAGEMENT INC | 481,765 | $17,435,000 | 1.71% |
| Perceptive Advisors | 589,890 | $21,348,000 | 1.38% |
| RA Capital Management | 318,565 | $11,529,000 | 1.19% |
| OAK RIDGE INVESTMENTS LLC | 1,226,468 | $44,386,000 | 1.15% |
| Granahan Investment Management | 817,149 | $29,573,000 | 0.97% |
| Eventide Asset Management | 428,900 | $15,522,000 | 0.95% |
| QVT Financial LP | 636,764 | $23,044,000 | 0.87% |